Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines?

Chemical Communications

Volumn , Issue 17, 2004, Pages 1889-1896

  Almarsson, Örn ^a,c   Zaworotko, Michael J ^b  

^a TransForm Pharmaceuticals Inc   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ACETIC ACID ETHYL ESTER; ACETONE; ALCOHOL; AMIDE; BENZENE; BENZOIC ACID DERIVATIVE; CARBON DISULFIDE; CARBON TETRACHLORIDE; CARBOXYLIC ACID DERIVATIVE; CHLOROFORM; ETHER; PHARMACEUTICAL VEHICLES AND ADDITIVES; PHENOL; SOLVENT;

CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; CHEMICAL ENGINEERING; CHEMICAL STRUCTURE; CRYSTAL; DRUG DESIGN; DRUG INDUSTRY; DRUG SYNTHESIS; HYDROGEN BOND; LIQUID; MOLECULAR SIZE; PHARMACEUTICS; PHYSICAL CHEMISTRY; REVIEW; ROOM TEMPERATURE; SOLID STATE; STRUCTURE ANALYSIS; SUPRAMOLECULAR CHEMISTRY; TECHNIQUE;

EID: 5044235632     PISSN: 13597345     EISSN: None     Source Type: Journal    
DOI: 10.1039/b402150a     Document Type: Review

References (76)

1. (a) G. R. Desiraju, Crystal Engineering-The Design of Organic Solids, Elsevier, Amsterdam, 1989;
2. (b) G. R. Desiraju, Angew. Chem., Int. Ed. Engl., 1995, 34, 2311-2327.
3. M. C. Etter, J. Chem. Phys., 1991, 95, 4601-4610; M. C. Etter, Acc. Chem. Res., 1990, 23, 120-126.
4. M. C. Etter, J. Chem. Phys., 1991, 95, 4601-4610; M. C. Etter, Acc. Chem. Res., 1990, 23, 120-126.
5. B. Moulton and M. J. Zaworotko, Chem. Rev., 2001, 101, 1629.
6. Ö. Almarsson, M. B. Hickey, M. L. Peterson, S. L. Morissette, C. McNulty, S. Soukasene, M. Tawa, M. MacPhee and J. F. Remenar, Cryst. Growth Des., 2003, 3, 927-933.
7. S. G. Fleischman, S. S. Kuduva, J. A. McMahon, B. Moulton, R. B. Walsh, N. Rodriguez-Hornedo and M. J. Zaworotko, Cryst. Growth Des., 2003, 3, 909-919.
8. S. G. Fleischman, L. Morales, B. Moulton, N. Rodríguez-Hornedo, R. B. Walsh and M. J. Zaworotko, Chem. Commun., 2003, 186-187.
9. S. Datta and D. J. W. Grant, Nat. Rev. Drug Discovery, 2004, 3, 42-57.
10. J. F. Remenar, S. L. Morissette, M. L. Peterson, B. Moulton, J. M. MacPhee, H. R. Guzman and Ö. Almarsson, J. Am. Chem. Soc., 2003, 125, 8456-8457.
11. I. D. H. Oswald, D. R. Allen, P. A. McGregor, W. D. S. Motherwell, S. Parsons and C. R. Pulham, Acta Crystallogr., 2002, B58, 1057-1066.
12. (a) J. K. Haleblian, J. Pharm. Sci., 1975, 64, 1269;
13. (b) J. Bernstein, Polymorphism in Molecular Crystals, Clarendon Press, Oxford, 2002.
14. L. Pauling, The Nature of the Chemical Bond, Cornell University Press, New York, 2nd edn., 1948.
15. R. Pepinsky, Phys. Rev., 1955, 100, 971.
16. G. M. Schmidt, Pure Appl. Chem., 1971, 27, 647.
17. F. Toda, Chem. Rev., 2000, 100, 1025-1074.
18. T. Friscic and L. R. MacGillivray, Chem. Commun., 2003, 1306-1307.
19. D. Braga, F. Grepioni and G. R. Desiraju, Chem. Rev., 1998, 98, 1375-1405.
20. R. C. Finn, J. Zubieta and R. C. Haushalter, Prog. Inorg. Chem., 2003, 51, 421-601.
21. (a) L. Leiserowitz and F. Nader, Angew. Chem., 1972, 84, 536;
22. (b) C. M. Huang, L. Leiserowitz and G. M. J. Schmidt, J. Chem. Soc. Perkins Trans. 2, 1973, 5, 503;
23. (c) Z. Berkovitch-Yellin, L. Leiserowitz and F. Nader, Acta Cryst., 1977, B33, 3670.
24. J. A. Kanters, G. Roelofsen and T. Feenstra, Acta. Cryst. B., 1976, 32, 3331.
25. J. A. Kanters and G. Roelofsen, Acta. Cryst. B., 1976, 32, 3328.
26. J. Bernstein and A. T. Hagler, J. Am. Chem. Soc., 1978, 100, 673-681.
27. G. V. Gridunova, Kristallografiya, 1982, 27, 267.
28. J. L. Derissen and P. H. Smit, Acta Cryst. B, 1974, 30, 2240.
29. V. Benghiat and L. Leiserowitz, J. Am. Chem. Soc. Perkins Trans. 2, 1972, 12, 1763.
30. F. H. Allen and O. Kennard, Chem. Des. Automation News, 1993, 8, 31.
31. M. Takasuka, H. Nakai and M. Shiro, J. Chem. Soc. Perkins Trans. 2, 1982, 9, 1061.
32. J. Dejace, Acta. Cryst., 1955, 8, 851.
33. B. R. Penfold and W. S. Simpson, Acta. Cryst., 1956, 9, 831.
34. B. Kalyanaraman, L. D. Kispert and J. L. Atwood, J. Cryst. Mol. Struct., 1978, 8, 175.
35. Y. Kato and N. Oguro, Mem. Osaka Kyoiku Univ. Ser. 3, 1982, 30, 155.
36. M. Katayama, Acta. Cryst., 1956, 9, 986.
37. G. Admiraal, J. C. Eikelenboom and A. Vos, Acta. Cryst. B., 1982, 38, 2600.
38. D. Louer, M. Louer, V. A. Dzyabchenko, V. Agafonov and R. Ceolin, Acta. Cryst. B., 1995, 51, 182.
39. J. A. McMahon, M. J. Zaworotko and J. F. Remenar, Chem. Commun., 2004, 278.
40. H. Verhagen, P. A. E. L. Schilderman and J. C. S. Kleinjans, Chem-Biol. Interactions, 1991, 80, 109.
41. J. W. Finley and P. Given Jr, Food Chem. Toxicol., 1986, 24, 999.
42. A. V.Trask, S. W. D. Motherwell and W. Jones, Chem. Commun., 2004, 890-891.
43. V. Videnova-Adrabinska and M. C. Etter, J. Chem. Cryst., 1995, 25, 823.
44. (a) C. B. Aakeroy, A. M. Beatty and B. A. Helfrich, Angew. Chem. Int. Ed. Engl., 2001, 40, 3240;
45. (b) C. B. Aakeroy, A. M. Beatty and B. A. Helfrich, J. Am. Chem. Soc., 2002, 124, 14425.
46. (a) S. Ohba, H. Hosomi and Y. Ito, J. Am. Chem. Soc., 2001, 123, 6349;
47. (b) Y. Ito, H. Hosomi and S. Ohba, Tetrahedron, 2000, 56, 6833;
48. (c) H. Hosomi, S. Ohba and Y. Ito, Acta. Cryst. C., 2000, 56, 507.
49. (a) G. Smith, K. E. Baldry, K. A. Byriel and C. H. L. Kennard, Aust. J. Chem., 1997, 50, 727;
50. (b) R. C. Bott, G. Smith, V. D. Wermuth and N. C. Dwyer, Aust. J. Chem., 2000, 53, 767;
51. (c) G. Smith, M. G. Coyne and J. M. White, Aust. J. Chem., 2000, 53, 203;
52. (d) T. J. M. Luo and G. T. R. Palmore, Cryst. Growth Des., 2002, 2, 337;
53. (e) P. Vishweshwar, A. Nangia and V. M. Lynch, Cryst. Growth Des., 2003, 3, 783-790;
54. (f) L. S. Reddy, A. Nangia and V. M. Lynch, Cryst. Growth Des., 2004, 4, 89-94.
55. S. Chatterjee, V. R. Pedireddi and C. N. R. Rao, Tetrahedron Lett., 1998, 39, 2843.
56. (a) J. Fabian, H. Nakazumi and M. Matsuoka, Chem. Rev., 1992, 92, 1197;
57. (b) G. de la Torre, P. Vazquez, F. Agullo-Lopez and T. Torres, J. Mater. Chem., 1998, 8, 1671.
58. G. Bettinetti, M. R. Caira, A. Callegari, M. Marcello, M. Sorrenti and C. Tadini, J. Pharm. Sci., 2000, 89, 478-489.
59. S. Morissette, Ö. Almarsson, M. Peterson, J. Remenar, M. Read, A. Lemmo, S. Ellis, M. Cima and C. Gardner, Adv. Drug Deliv. Rev., 2004, 56(3), 275-300.
60. A. L. Bingham, D. S. Hughes, M. B. Hursthouse, R. W. Lancaster, S. Tavener and T. L. Threlfall, Chem. Comm., 2001, 603.
61. P. H. Stahl and M. Nakano, Pharmaceutical Aspects of the Drug Salt Form, in Handbook of Pharmaceutical Salts: Properties, Selection, and Use, ed. P. H. Stahl and C. G. Wermuth, Wiley-VCH/VCHA, New York, 2002.
62. S. M. Berge, L. D. Bighley and D. C. Monkhouse, J. Pharm. Sci., 1977, 66, 1-19.
63. J. F. Remenar, J. M. MacPhee, B. K. Larson, V. A. Tyagi, J. H. Ho, D. A. McIlroy, M. B. Hickey, P. B. Shaw and O. Almarsson, Org. Process. Res. Dev., 2003, 7, 990-996 and references therein.
64. P. L. Gould, Int. J. Pharm., 1986, 33, 201.
65. A. L. Grzesiak, M. Lang, K. Kim and A. J. Matzger, J. Pharm. Sci., 2003, 92, 2260.
66. F. U. Krahn and J. B. Mielck, Pharm. Acta Helv., 1987, 62, 247.
67. M. B. Hickey, personal communication.
68. J. A. Zerkowski, J. C. MacDonald and G. M. Whitesides, Chem. Mater., 1997, 9, 1933.
69. S.-D. Clas, Curr. Opin. Drug Disc. Dev., 2003, 6, 550.
70. Ö. Almarsson and C. R. Gardner, Current Drug Discovery, 2003, pp. 21-26.
71. (a) S. R. Byrn, R. R. Pfeiffer and J. G. Stowell, Solid-State Chemistry of Drugs, SSCI, Inc., West Lafayette, IN, 1999;
72. (b) S. R. Byrn, A. W. Newman and W. Xu, Adv. Drug Deliv. Rev., 2000, 48, 115.
73. B. C. Hancock and M. Parks, Pharm. Res., 2000, 17, 397-404.
74. S.-D. Clas, M. Cotton, E. Moran, S. Spagnoli, G. Zografi and E. B. Vadas, Thermochim. Acta., 1996, 288, 83.
75. N. Rodriguez-Hornedo, personal communication.
76. Y. Kobayashi, S. Ito, S. Itai and K. Yamamoto, Int. J. Pharm., 2000, 193, 137.